Literature DB >> 18849602

Nicotine augments glomerular injury in a rat model of acute nephritis.

Edgar A Jaimes1, Run-Xia Tian, Mahesh S Joshi, Leopoldo Raij.   

Abstract

BACKGROUND/AIMS: Epidemiologic studies suggest that cigarette smoke worsens the progression of renal injury in patients with glomerular diseases. The mechanisms involved have not been elucidated. These studies were designed to determine whether nicotine worsens markers of inflammation including glomerular cell proliferation and fibronectin deposition in an in vivo model of glomerular injury.
METHODS: Sprague-Dawley rats were injected with anti-Thy1 antibody and given either tap water or nicotine in the drinking water until sacrifice at day 14. Fibronectin expression was measured by Western blot and immunohistochemistry. COX-2 expression was also determined by Western blot in the kidney cortex of rats treated with nicotine and in cultured human mesangial cells treated with nicotine.
RESULTS: Anti-Thy1 antibody administration resulted in a significant increase in the number of cells per glomerulus that was further increased by the administration of nicotine. In nephritic rats, the administration of nicotine significantly increased fibronectin and COX-2 expression. In cultured human mesangial cells we also demonstrated that nicotine increases COX-2 expression and activity and that COX-2 mediates mesangial cell proliferation in response to nicotine.
CONCLUSION: Either in vivo or in vitro treatment with nicotine leads to activation of inflammatory mediators and hallmarks of glomerular injury, which may explain the mechanisms involved in the deleterious effects of cigarette smoking on renal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849602      PMCID: PMC7265426          DOI: 10.1159/000163593

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  41 in total

1.  Evaluation of urothelial stretch-induced cyclooxygenase-2 expression in novel human cell culture and porcine in vivo ureteral obstruction models.

Authors:  Travis J Jerde; William S Mellon; Dale E Bjorling; Stephen Y Nakada
Journal:  J Pharmacol Exp Ther       Date:  2006-02-28       Impact factor: 4.030

2.  Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis.

Authors:  Prasun K Datta; Shawn Dhupar; Elias A Lianos
Journal:  Nephrol Dial Transplant       Date:  2005-10-04       Impact factor: 5.992

Review 3.  Cyclooxygenase in biology and disease.

Authors:  R N Dubois; S B Abramson; L Crofford; R A Gupta; L S Simon; L B Van De Putte; P E Lipsky
Journal:  FASEB J       Date:  1998-09       Impact factor: 5.191

4.  Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species.

Authors:  Edgar A Jaimes; Run-Xia Tian; Damien Pearse; Leopoldo Raij
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

Review 5.  The health consequences of smoking. Cardiovascular diseases.

Authors:  P E McBride
Journal:  Med Clin North Am       Date:  1992-03       Impact factor: 5.456

6.  Enhanced expression of membrane type-1 matrix metalloproteinase in mesangial proliferative glomerulonephritis.

Authors:  K Hayashi; S Osada; K Shofuda; S Horikoshi; I Shirato; Y Tomino
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

7.  Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase.

Authors:  Yongzhong Wei; James R Sowers; Suzanne E Clark; Wenhan Li; Carlos M Ferrario; Craig S Stump
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-12-11       Impact factor: 4.310

8.  Human vascular endothelial cells express functional nicotinic acetylcholine receptors.

Authors:  K D Macklin; A D Maus; E F Pereira; E X Albuquerque; B M Conti-Fine
Journal:  J Pharmacol Exp Ther       Date:  1998-10       Impact factor: 4.030

9.  Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage.

Authors:  Norbert Henke; Ruth Schmidt-Ullrich; Ralf Dechend; Joon-Keun Park; Fatimunnisa Qadri; Maren Wellner; Michael Obst; Volkmar Gross; Rainer Dietz; Friedrich C Luft; Claus Scheidereit; Dominik N Muller
Journal:  Circ Res       Date:  2007-06-21       Impact factor: 17.367

10.  Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect.

Authors:  Ling Yu; Wayne A Border; Ian Anderson; Matthew McCourt; Yufeng Huang; Nancy A Noble
Journal:  Kidney Int       Date:  2004-11       Impact factor: 18.998

View more
  27 in total

1.  AGEs-RAGE overexpression in a patient with smoking-related idiopathic nodular glomerulosclerosis.

Authors:  Nao Nakamura; Kensei Taguchi; Yoshihiro Miyazono; Keiichiro Uemura; Kiyomi Koike; Yuka Kurokawa; Yosuke Nakayama; Yusuke Kaida; Ryo Shibata; Akihiro Tsuchimoto; Katsuhiko Asanuma; Kei Fukami
Journal:  CEN Case Rep       Date:  2017-11-27

2.  Genetic variants in nicotinic acetylcholine receptor genes jointly contribute to kidney function in American Indians: the Strong Heart Family Study.

Authors:  Yun Zhu; Jingyun Yang; Shengxu Li; Shelley A Cole; Karin Haack; Jason G Umans; Nora Franceschini; Barbara V Howard; Elisa T Lee; Jinying Zhao
Journal:  J Hypertens       Date:  2014-05       Impact factor: 4.844

3.  The interrelationship between urinary cotinine and nicotine dependence among tobacco users in an Indian de-addiction centre: A cohort pilot study.

Authors:  Nalini M Vinoth Kumar; Shahnawaz Khijmatgar; Avidyuti Chowdhury; Martin Gootveld; Edward Lynch; Chitta Chowdhury
Journal:  J Oral Biol Craniofac Res       Date:  2019-07-15

4.  Smoking patterns and chronic kidney disease in US Hispanics: Hispanic Community Health Study/Study of Latinos.

Authors:  Nora Franceschini; Yu Deng; Michael F Flessner; John H Eckfeldt; Holly J Kramer; James P Lash; David J Lee; Michal L Melamed; Ashley E Moncrieft; Ana C Ricardo; Sylvia E Rosas; Robert C Kaplan; Leopoldo Raij; Jianwen Cai
Journal:  Nephrol Dial Transplant       Date:  2016-06-02       Impact factor: 5.992

5.  COX-2-derived prostaglandins as mediators of the deleterious effects of nicotine in chronic kidney disease.

Authors:  S Rangarajan; G Rezonzew; P Chumley; H Fatima; M Y Golovko; W Feng; P Hua; E A Jaimes
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-16

6.  Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers.

Authors:  Ping Hua; Wenguang Feng; Shaonin Ji; Leopoldo Raij; Edgar A Jaimes
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-04

7.  Duration-dependent effects of nicotine exposure on growth and AKT activation in human kidney epithelial cells.

Authors:  Yu-Wei Chang; Kamaleshwar P Singh
Journal:  Mol Cell Biochem       Date:  2018-02-02       Impact factor: 3.396

8.  Selenium nanoparticles with low-level ionizing radiation exposure ameliorate nicotine-induced inflammatory impairment in rat kidney.

Authors:  Walid E Zahran; Sawsan M Elsonbaty; Fatma S M Moawed
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-09       Impact factor: 4.223

9.  Nicotine exposure and the progression of chronic kidney disease: role of the α7-nicotinic acetylcholine receptor.

Authors:  Gabriel Rezonzew; Phillip Chumley; Wenguang Feng; Ping Hua; Gene P Siegal; Edgar A Jaimes
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-02

10.  Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc.

Authors:  Istvan Arany; Jeb Clark; Dustin K Reed; Luis A Juncos
Journal:  Nephrol Dial Transplant       Date:  2013-01-16       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.